vs

Side-by-side financial comparison of ARGENX SE (ARGX) and Taylor Morrison Home Corp (TMHC). Click either name above to swap in a different company.

ARGENX SE is the larger business by last-quarter revenue ($2.5B vs $1.4B, roughly 1.8× Taylor Morrison Home Corp). ARGENX SE runs the higher net margin — 35.5% vs 7.1%, a 28.4% gap on every dollar of revenue. On growth, ARGENX SE posted the faster year-over-year revenue change (83.2% vs -26.8%).

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

Taylor Morrison is one of the largest home building companies in the United States. Its corporate headquarters are in Scottsdale, Arizona. The company formed when Taylor Woodrow and Morrison Homes joined forces in July 2007. Taylor Morrison operates in Arizona, California, Colorado, Georgia, Florida, North Carolina, South Carolina, Nevada, Indiana, and Texas, building mid-to-upscale housing, as well as first-time and mid-market homes.

ARGX vs TMHC — Head-to-Head

Bigger by revenue
ARGX
ARGX
1.8× larger
ARGX
$2.5B
$1.4B
TMHC
Growing faster (revenue YoY)
ARGX
ARGX
+110.1% gap
ARGX
83.2%
-26.8%
TMHC
Higher net margin
ARGX
ARGX
28.4% more per $
ARGX
35.5%
7.1%
TMHC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ARGX
ARGX
TMHC
TMHC
Revenue
$2.5B
$1.4B
Net Profit
$877.2M
$98.6M
Gross Margin
89.5%
21.0%
Operating Margin
28.9%
Net Margin
35.5%
7.1%
Revenue YoY
83.2%
-26.8%
Net Profit YoY
1.3%
-53.8%
EPS (diluted)
$13.25
$1.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARGX
ARGX
TMHC
TMHC
Q1 26
$1.4B
Q4 25
$2.5B
$2.1B
Q3 25
$2.1B
Q2 25
$1.8B
$2.0B
Q1 25
$1.9B
Q4 24
$1.4B
$2.4B
Q3 24
$2.1B
Q2 24
$901.9M
$2.0B
Net Profit
ARGX
ARGX
TMHC
TMHC
Q1 26
$98.6M
Q4 25
$877.2M
$174.0M
Q3 25
$201.4M
Q2 25
$414.8M
$193.6M
Q1 25
$213.5M
Q4 24
$865.6M
$242.5M
Q3 24
$251.1M
Q2 24
$-32.5M
$199.5M
Gross Margin
ARGX
ARGX
TMHC
TMHC
Q1 26
21.0%
Q4 25
89.5%
22.0%
Q3 25
22.7%
Q2 25
89.2%
23.0%
Q1 25
24.4%
Q4 24
90.2%
23.9%
Q3 24
25.0%
Q2 24
89.4%
23.7%
Operating Margin
ARGX
ARGX
TMHC
TMHC
Q1 26
Q4 25
28.9%
Q3 25
Q2 25
19.2%
Q1 25
Q4 24
8.7%
Q3 24
Q2 24
-15.4%
Net Margin
ARGX
ARGX
TMHC
TMHC
Q1 26
7.1%
Q4 25
35.5%
8.3%
Q3 25
9.6%
Q2 25
23.4%
9.5%
Q1 25
11.3%
Q4 24
64.1%
10.3%
Q3 24
11.8%
Q2 24
-3.6%
10.0%
EPS (diluted)
ARGX
ARGX
TMHC
TMHC
Q1 26
$1.12
Q4 25
$13.25
$1.77
Q3 25
$2.01
Q2 25
$6.32
$1.92
Q1 25
$2.07
Q4 24
$13.33
$2.29
Q3 24
$2.37
Q2 24
$-0.55
$1.86

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARGX
ARGX
TMHC
TMHC
Cash + ST InvestmentsLiquidity on hand
$3.5B
$652.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$7.3B
$6.2B
Total Assets
$8.7B
$9.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARGX
ARGX
TMHC
TMHC
Q1 26
$652.9M
Q4 25
$3.5B
$850.0M
Q3 25
$370.6M
Q2 25
$2.1B
$130.2M
Q1 25
$377.8M
Q4 24
$1.5B
$487.2M
Q3 24
$256.4M
Q2 24
$1.4B
$246.8M
Total Debt
ARGX
ARGX
TMHC
TMHC
Q1 26
Q4 25
$2.3B
Q3 25
$2.2B
Q2 25
$2.1B
Q1 25
$2.1B
Q4 24
$2.1B
Q3 24
$2.1B
Q2 24
$11.0M
$2.2B
Stockholders' Equity
ARGX
ARGX
TMHC
TMHC
Q1 26
$6.2B
Q4 25
$7.3B
$6.3B
Q3 25
$6.2B
Q2 25
$6.1B
$6.1B
Q1 25
$6.0B
Q4 24
$5.5B
$5.9B
Q3 24
$5.7B
Q2 24
$4.3B
$5.5B
Total Assets
ARGX
ARGX
TMHC
TMHC
Q1 26
$9.8B
Q4 25
$8.7B
$9.8B
Q3 25
$9.6B
Q2 25
$7.2B
$9.5B
Q1 25
$9.4B
Q4 24
$6.2B
$9.3B
Q3 24
$9.3B
Q2 24
$4.8B
$9.1B
Debt / Equity
ARGX
ARGX
TMHC
TMHC
Q1 26
Q4 25
0.36×
Q3 25
0.35×
Q2 25
0.35×
Q1 25
0.35×
Q4 24
0.36×
Q3 24
0.37×
Q2 24
0.00×
0.39×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARGX
ARGX
TMHC
TMHC
Operating Cash FlowLast quarter
$323.3M
Free Cash FlowOCF − Capex
$322.4M
FCF MarginFCF / Revenue
13.0%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
0.37×
TTM Free Cash FlowTrailing 4 quarters
$594.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARGX
ARGX
TMHC
TMHC
Q1 26
Q4 25
$323.3M
$646.4M
Q3 25
$219.6M
Q2 25
$361.8M
$-126.0M
Q1 25
$77.2M
Q4 24
$41.9M
$438.2M
Q3 24
$135.9M
Q2 24
$-124.7M
$-233.3M
Free Cash Flow
ARGX
ARGX
TMHC
TMHC
Q1 26
Q4 25
$322.4M
$635.3M
Q3 25
$206.6M
Q2 25
$356.6M
$-133.6M
Q1 25
$68.7M
Q4 24
$40.9M
$428.2M
Q3 24
$127.1M
Q2 24
$-125.5M
$-241.7M
FCF Margin
ARGX
ARGX
TMHC
TMHC
Q1 26
Q4 25
13.0%
30.3%
Q3 25
9.9%
Q2 25
20.1%
-6.6%
Q1 25
3.6%
Q4 24
3.0%
18.2%
Q3 24
6.0%
Q2 24
-13.9%
-12.1%
Capex Intensity
ARGX
ARGX
TMHC
TMHC
Q1 26
Q4 25
0.0%
0.5%
Q3 25
0.6%
Q2 25
0.3%
0.4%
Q1 25
0.4%
Q4 24
0.1%
0.4%
Q3 24
0.4%
Q2 24
0.1%
0.4%
Cash Conversion
ARGX
ARGX
TMHC
TMHC
Q1 26
Q4 25
0.37×
3.71×
Q3 25
1.09×
Q2 25
0.87×
-0.65×
Q1 25
0.36×
Q4 24
0.05×
1.81×
Q3 24
0.54×
Q2 24
-1.17×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARGX
ARGX

Segment breakdown not available.

TMHC
TMHC

Home closings revenue, net$1.3B95%
Financial services revenue, net$49.3M4%
Land closings revenue$14.5M1%
Amenity and other revenue$11.9M1%

Related Comparisons